wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28275648-44C8D839-F65F-4A1E-AC58-71CDFFB3E3F2
Q28275648-44C8D839-F65F-4A1E-AC58-71CDFFB3E3F2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28275648-44C8D839-F65F-4A1E-AC58-71CDFFB3E3F2
PCSK9 Inhibition With Monoclonal Antibodies: Modern Management of Hypercholesterolemia
P2860
Q28275648-44C8D839-F65F-4A1E-AC58-71CDFFB3E3F2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28275648-44C8D839-F65F-4A1E-AC58-71CDFFB3E3F2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e7cd1002f6059d281ef0467d0493af9347e57604
P2860
Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial.